Global Cognition-Enhancing Drugs Market Growth 2025-2031

December 2025 | 81 pages | ID: GBEB6A108AAEN
LP Information

Abstracts

The global Cognition-Enhancing Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Cognition-enhancing drugs are purported to improve mental functions such as cognition, memory, intelligence, motivation, attention and concentration.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Cognition-Enhancing Drugs Industry Forecast” looks at past sales and reviews total world Cognition-Enhancing Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Cognition-Enhancing Drugs sales for 2025 through 2031. With Cognition-Enhancing Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cognition-Enhancing Drugs industry.

This Insight Report provides a comprehensive analysis of the global Cognition-Enhancing Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cognition-Enhancing Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cognition-Enhancing Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cognition-Enhancing Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cognition-Enhancing Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Cognition-Enhancing Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Oral
• Injection

Segmentation by Application:

• Hospital Pharmacies
• Drug Stores
• Retail Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Accelerated Intelligence
• Cognition Therapeutics
• Cogstate
• HVMN
• Biogen Idec

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cognition-Enhancing Drugs market?

What factors are driving Cognition-Enhancing Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cognition-Enhancing Drugs market opportunities vary by end market size?

How does Cognition-Enhancing Drugs break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cognition-Enhancing Drugs Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Cognition-Enhancing Drugs by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Cognition-Enhancing Drugs by Country/Region, 2020, 2024 & 2031
2.2 Cognition-Enhancing Drugs Segment by Type
  2.2.1 Oral
  2.2.2 Injection
2.3 Cognition-Enhancing Drugs Sales by Type
  2.3.1 Global Cognition-Enhancing Drugs Sales Market Share by Type (2020-2025)
  2.3.2 Global Cognition-Enhancing Drugs Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Cognition-Enhancing Drugs Sale Price by Type (2020-2025)
2.4 Cognition-Enhancing Drugs Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Drug Stores
  2.4.3 Retail Pharmacies
2.5 Cognition-Enhancing Drugs Sales by Application
  2.5.1 Global Cognition-Enhancing Drugs Sale Market Share by Application (2020-2025)
  2.5.2 Global Cognition-Enhancing Drugs Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Cognition-Enhancing Drugs Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Cognition-Enhancing Drugs Breakdown Data by Company
  3.1.1 Global Cognition-Enhancing Drugs Annual Sales by Company (2020-2025)
  3.1.2 Global Cognition-Enhancing Drugs Sales Market Share by Company (2020-2025)
3.2 Global Cognition-Enhancing Drugs Annual Revenue by Company (2020-2025)
  3.2.1 Global Cognition-Enhancing Drugs Revenue by Company (2020-2025)
  3.2.2 Global Cognition-Enhancing Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Cognition-Enhancing Drugs Sale Price by Company
3.4 Key Manufacturers Cognition-Enhancing Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Cognition-Enhancing Drugs Product Location Distribution
  3.4.2 Players Cognition-Enhancing Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR COGNITION-ENHANCING DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Cognition-Enhancing Drugs Market Size by Geographic Region (2020-2025)
  4.1.1 Global Cognition-Enhancing Drugs Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Cognition-Enhancing Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Cognition-Enhancing Drugs Market Size by Country/Region (2020-2025)
  4.2.1 Global Cognition-Enhancing Drugs Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Cognition-Enhancing Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cognition-Enhancing Drugs Sales Growth
4.4 APAC Cognition-Enhancing Drugs Sales Growth
4.5 Europe Cognition-Enhancing Drugs Sales Growth
4.6 Middle East & Africa Cognition-Enhancing Drugs Sales Growth

5 AMERICAS

5.1 Americas Cognition-Enhancing Drugs Sales by Country
  5.1.1 Americas Cognition-Enhancing Drugs Sales by Country (2020-2025)
  5.1.2 Americas Cognition-Enhancing Drugs Revenue by Country (2020-2025)
5.2 Americas Cognition-Enhancing Drugs Sales by Type (2020-2025)
5.3 Americas Cognition-Enhancing Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cognition-Enhancing Drugs Sales by Region
  6.1.1 APAC Cognition-Enhancing Drugs Sales by Region (2020-2025)
  6.1.2 APAC Cognition-Enhancing Drugs Revenue by Region (2020-2025)
6.2 APAC Cognition-Enhancing Drugs Sales by Type (2020-2025)
6.3 APAC Cognition-Enhancing Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Cognition-Enhancing Drugs by Country
  7.1.1 Europe Cognition-Enhancing Drugs Sales by Country (2020-2025)
  7.1.2 Europe Cognition-Enhancing Drugs Revenue by Country (2020-2025)
7.2 Europe Cognition-Enhancing Drugs Sales by Type (2020-2025)
7.3 Europe Cognition-Enhancing Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cognition-Enhancing Drugs by Country
  8.1.1 Middle East & Africa Cognition-Enhancing Drugs Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Cognition-Enhancing Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Cognition-Enhancing Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Cognition-Enhancing Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cognition-Enhancing Drugs
10.3 Manufacturing Process Analysis of Cognition-Enhancing Drugs
10.4 Industry Chain Structure of Cognition-Enhancing Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Cognition-Enhancing Drugs Distributors
11.3 Cognition-Enhancing Drugs Customer

12 WORLD FORECAST REVIEW FOR COGNITION-ENHANCING DRUGS BY GEOGRAPHIC REGION

12.1 Global Cognition-Enhancing Drugs Market Size Forecast by Region
  12.1.1 Global Cognition-Enhancing Drugs Forecast by Region (2026-2031)
  12.1.2 Global Cognition-Enhancing Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Cognition-Enhancing Drugs Forecast by Type (2026-2031)
12.7 Global Cognition-Enhancing Drugs Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Accelerated Intelligence
  13.1.1 Accelerated Intelligence Company Information
  13.1.2 Accelerated Intelligence Cognition-Enhancing Drugs Product Portfolios and Specifications
  13.1.3 Accelerated Intelligence Cognition-Enhancing Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Accelerated Intelligence Main Business Overview
  13.1.5 Accelerated Intelligence Latest Developments
13.2 Cognition Therapeutics
  13.2.1 Cognition Therapeutics Company Information
  13.2.2 Cognition Therapeutics Cognition-Enhancing Drugs Product Portfolios and Specifications
  13.2.3 Cognition Therapeutics Cognition-Enhancing Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Cognition Therapeutics Main Business Overview
  13.2.5 Cognition Therapeutics Latest Developments
13.3 Cogstate
  13.3.1 Cogstate Company Information
  13.3.2 Cogstate Cognition-Enhancing Drugs Product Portfolios and Specifications
  13.3.3 Cogstate Cognition-Enhancing Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Cogstate Main Business Overview
  13.3.5 Cogstate Latest Developments
13.4 HVMN
  13.4.1 HVMN Company Information
  13.4.2 HVMN Cognition-Enhancing Drugs Product Portfolios and Specifications
  13.4.3 HVMN Cognition-Enhancing Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 HVMN Main Business Overview
  13.4.5 HVMN Latest Developments
13.5 Biogen Idec
  13.5.1 Biogen Idec Company Information
  13.5.2 Biogen Idec Cognition-Enhancing Drugs Product Portfolios and Specifications
  13.5.3 Biogen Idec Cognition-Enhancing Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Biogen Idec Main Business Overview
  13.5.5 Biogen Idec Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cognition-Enhancing Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Cognition-Enhancing Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Global Cognition-Enhancing Drugs Sales by Type (2020-2025) & (K MT)
Table 6. Global Cognition-Enhancing Drugs Sales Market Share by Type (2020-2025)
Table 7. Global Cognition-Enhancing Drugs Revenue by Type (2020-2025) & ($ million)
Table 8. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2020-2025)
Table 9. Global Cognition-Enhancing Drugs Sale Price by Type (2020-2025) & (USD/MT)
Table 10. Global Cognition-Enhancing Drugs Sale by Application (2020-2025) & (K MT)
Table 11. Global Cognition-Enhancing Drugs Sale Market Share by Application (2020-2025)
Table 12. Global Cognition-Enhancing Drugs Revenue by Application (2020-2025) & ($ million)
Table 13. Global Cognition-Enhancing Drugs Revenue Market Share by Application (2020-2025)
Table 14. Global Cognition-Enhancing Drugs Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Cognition-Enhancing Drugs Sales by Company (2020-2025) & (K MT)
Table 16. Global Cognition-Enhancing Drugs Sales Market Share by Company (2020-2025)
Table 17. Global Cognition-Enhancing Drugs Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Cognition-Enhancing Drugs Revenue Market Share by Company (2020-2025)
Table 19. Global Cognition-Enhancing Drugs Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Cognition-Enhancing Drugs Producing Area Distribution and Sales Area
Table 21. Players Cognition-Enhancing Drugs Products Offered
Table 22. Cognition-Enhancing Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Cognition-Enhancing Drugs Sales by Geographic Region (2020-2025) & (K MT)
Table 26. Global Cognition-Enhancing Drugs Sales Market Share Geographic Region (2020-2025)
Table 27. Global Cognition-Enhancing Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Cognition-Enhancing Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Cognition-Enhancing Drugs Sales by Country/Region (2020-2025) & (K MT)
Table 30. Global Cognition-Enhancing Drugs Sales Market Share by Country/Region (2020-2025)
Table 31. Global Cognition-Enhancing Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Cognition-Enhancing Drugs Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Cognition-Enhancing Drugs Sales by Country (2020-2025) & (K MT)
Table 34. Americas Cognition-Enhancing Drugs Sales Market Share by Country (2020-2025)
Table 35. Americas Cognition-Enhancing Drugs Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Cognition-Enhancing Drugs Sales by Type (2020-2025) & (K MT)
Table 37. Americas Cognition-Enhancing Drugs Sales by Application (2020-2025) & (K MT)
Table 38. APAC Cognition-Enhancing Drugs Sales by Region (2020-2025) & (K MT)
Table 39. APAC Cognition-Enhancing Drugs Sales Market Share by Region (2020-2025)
Table 40. APAC Cognition-Enhancing Drugs Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Cognition-Enhancing Drugs Sales by Type (2020-2025) & (K MT)
Table 42. APAC Cognition-Enhancing Drugs Sales by Application (2020-2025) & (K MT)
Table 43. Europe Cognition-Enhancing Drugs Sales by Country (2020-2025) & (K MT)
Table 44. Europe Cognition-Enhancing Drugs Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Cognition-Enhancing Drugs Sales by Type (2020-2025) & (K MT)
Table 46. Europe Cognition-Enhancing Drugs Sales by Application (2020-2025) & (K MT)
Table 47. Middle East & Africa Cognition-Enhancing Drugs Sales by Country (2020-2025) & (K MT)
Table 48. Middle East & Africa Cognition-Enhancing Drugs Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Cognition-Enhancing Drugs Sales by Type (2020-2025) & (K MT)
Table 50. Middle East & Africa Cognition-Enhancing Drugs Sales by Application (2020-2025) & (K MT)
Table 51. Key Market Drivers & Growth Opportunities of Cognition-Enhancing Drugs
Table 52. Key Market Challenges & Risks of Cognition-Enhancing Drugs
Table 53. Key Industry Trends of Cognition-Enhancing Drugs
Table 54. Cognition-Enhancing Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Cognition-Enhancing Drugs Distributors List
Table 57. Cognition-Enhancing Drugs Customer List
Table 58. Global Cognition-Enhancing Drugs Sales Forecast by Region (2026-2031) & (K MT)
Table 59. Global Cognition-Enhancing Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Cognition-Enhancing Drugs Sales Forecast by Country (2026-2031) & (K MT)
Table 61. Americas Cognition-Enhancing Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Cognition-Enhancing Drugs Sales Forecast by Region (2026-2031) & (K MT)
Table 63. APAC Cognition-Enhancing Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Cognition-Enhancing Drugs Sales Forecast by Country (2026-2031) & (K MT)
Table 65. Europe Cognition-Enhancing Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Cognition-Enhancing Drugs Sales Forecast by Country (2026-2031) & (K MT)
Table 67. Middle East & Africa Cognition-Enhancing Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Cognition-Enhancing Drugs Sales Forecast by Type (2026-2031) & (K MT)
Table 69. Global Cognition-Enhancing Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Cognition-Enhancing Drugs Sales Forecast by Application (2026-2031) & (K MT)
Table 71. Global Cognition-Enhancing Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Accelerated Intelligence Basic Information, Cognition-Enhancing Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Accelerated Intelligence Cognition-Enhancing Drugs Product Portfolios and Specifications
Table 74. Accelerated Intelligence Cognition-Enhancing Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Accelerated Intelligence Main Business
Table 76. Accelerated Intelligence Latest Developments
Table 77. Cognition Therapeutics Basic Information, Cognition-Enhancing Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Cognition Therapeutics Cognition-Enhancing Drugs Product Portfolios and Specifications
Table 79. Cognition Therapeutics Cognition-Enhancing Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Cognition Therapeutics Main Business
Table 81. Cognition Therapeutics Latest Developments
Table 82. Cogstate Basic Information, Cognition-Enhancing Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Cogstate Cognition-Enhancing Drugs Product Portfolios and Specifications
Table 84. Cogstate Cognition-Enhancing Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Cogstate Main Business
Table 86. Cogstate Latest Developments
Table 87. HVMN Basic Information, Cognition-Enhancing Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. HVMN Cognition-Enhancing Drugs Product Portfolios and Specifications
Table 89. HVMN Cognition-Enhancing Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. HVMN Main Business
Table 91. HVMN Latest Developments
Table 92. Biogen Idec Basic Information, Cognition-Enhancing Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Biogen Idec Cognition-Enhancing Drugs Product Portfolios and Specifications
Table 94. Biogen Idec Cognition-Enhancing Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Biogen Idec Main Business
Table 96. Biogen Idec Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Cognition-Enhancing Drugs
Figure 2. Cognition-Enhancing Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cognition-Enhancing Drugs Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Cognition-Enhancing Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Cognition-Enhancing Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Cognition-Enhancing Drugs Sales Market Share by Country/Region (2024)
Figure 10. Cognition-Enhancing Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Injection
Figure 13. Global Cognition-Enhancing Drugs Sales Market Share by Type in 2025
Figure 14. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2020-2025)
Figure 15. Cognition-Enhancing Drugs Consumed in Hospital Pharmacies
Figure 16. Global Cognition-Enhancing Drugs Market: Hospital Pharmacies (2020-2025) & (K MT)
Figure 17. Cognition-Enhancing Drugs Consumed in Drug Stores
Figure 18. Global Cognition-Enhancing Drugs Market: Drug Stores (2020-2025) & (K MT)
Figure 19. Cognition-Enhancing Drugs Consumed in Retail Pharmacies
Figure 20. Global Cognition-Enhancing Drugs Market: Retail Pharmacies (2020-2025) & (K MT)
Figure 21. Global Cognition-Enhancing Drugs Sale Market Share by Application (2024)
Figure 22. Global Cognition-Enhancing Drugs Revenue Market Share by Application in 2025
Figure 23. Cognition-Enhancing Drugs Sales by Company in 2025 (K MT)
Figure 24. Global Cognition-Enhancing Drugs Sales Market Share by Company in 2025
Figure 25. Cognition-Enhancing Drugs Revenue by Company in 2025 ($ millions)
Figure 26. Global Cognition-Enhancing Drugs Revenue Market Share by Company in 2025
Figure 27. Global Cognition-Enhancing Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Cognition-Enhancing Drugs Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Cognition-Enhancing Drugs Sales 2020-2025 (K MT)
Figure 30. Americas Cognition-Enhancing Drugs Revenue 2020-2025 ($ millions)
Figure 31. APAC Cognition-Enhancing Drugs Sales 2020-2025 (K MT)
Figure 32. APAC Cognition-Enhancing Drugs Revenue 2020-2025 ($ millions)
Figure 33. Europe Cognition-Enhancing Drugs Sales 2020-2025 (K MT)
Figure 34. Europe Cognition-Enhancing Drugs Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Cognition-Enhancing Drugs Sales 2020-2025 (K MT)
Figure 36. Middle East & Africa Cognition-Enhancing Drugs Revenue 2020-2025 ($ millions)
Figure 37. Americas Cognition-Enhancing Drugs Sales Market Share by Country in 2025
Figure 38. Americas Cognition-Enhancing Drugs Revenue Market Share by Country (2020-2025)
Figure 39. Americas Cognition-Enhancing Drugs Sales Market Share by Type (2020-2025)
Figure 40. Americas Cognition-Enhancing Drugs Sales Market Share by Application (2020-2025)
Figure 41. United States Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Cognition-Enhancing Drugs Sales Market Share by Region in 2025
Figure 46. APAC Cognition-Enhancing Drugs Revenue Market Share by Region (2020-2025)
Figure 47. APAC Cognition-Enhancing Drugs Sales Market Share by Type (2020-2025)
Figure 48. APAC Cognition-Enhancing Drugs Sales Market Share by Application (2020-2025)
Figure 49. China Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. India Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Cognition-Enhancing Drugs Sales Market Share by Country in 2025
Figure 57. Europe Cognition-Enhancing Drugs Revenue Market Share by Country (2020-2025)
Figure 58. Europe Cognition-Enhancing Drugs Sales Market Share by Type (2020-2025)
Figure 59. Europe Cognition-Enhancing Drugs Sales Market Share by Application (2020-2025)
Figure 60. Germany Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 61. France Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Application (2020-2025)
Figure 68. Egypt Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Cognition-Enhancing Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Cognition-Enhancing Drugs in 2025
Figure 74. Manufacturing Process Analysis of Cognition-Enhancing Drugs
Figure 75. Industry Chain Structure of Cognition-Enhancing Drugs
Figure 76. Channels of Distribution
Figure 77. Global Cognition-Enhancing Drugs Sales Market Forecast by Region (2026-2031)
Figure 78. Global Cognition-Enhancing Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Cognition-Enhancing Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Cognition-Enhancing Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Cognition-Enhancing Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Cognition-Enhancing Drugs Revenue Market Share Forecast by Application (2026-2031)